Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan M Kraaijenhof

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
European Heart Journal|November 28, 2025
The value of low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) in guiding cardiovascular preventionPaul M Ridker, Jordan M Kraaijenhof
JACC. Basic to Translational Science|June 16, 2023
Inflammatory Effects of Triglycerides: Relevant or Redundant?Jordan M Kraaijenhof, Erik S G Stroes
NEJM Evidence|February 6, 2024
Apolipoprotein C-III Inhibition - Killing Two Birds with One Stone?Jordan M Kraaijenhof, Erik S G Stroes
European Heart Journal|August 20, 2022
Different inflammatory pathways underlying cardiovascular risk in secondary preventionNick S Nurmohamed, Jordan M Kraaijenhof, Erik S G Stroes
European Heart Journal|July 24, 2025
A stitch in time: easily measured biomarkers to enhance cardiovascular risk prediction in primary preventionJordan M Kraaijenhof, Nick S Nurmohamed, Paul M Ridker
Current Atherosclerosis Reports|September 6, 2022
Lp(a): a New Pathway to Target?Nick S Nurmohamed, Jordan M Kraaijenhof, Erik S G Stroes
European Journal of Preventive Cardiology|May 9, 2026
ASCVD Risk Stratification Using Apolipoprotein B and the LDL-C to Total Cholesterol RatioBin Wang, Nick S Nurmohamed, Jordan M Kraaijenhof, et al.
Current Opinion in Lipidology|August 15, 2021
The iterative lipid impact on inflammation in atherosclerosisJordan M Kraaijenhof, G Kees Hovingh, Erik S G Stroes, et al.
Frontiers in Cell and Developmental Biology|August 20, 2024
Moving from lipids to leukocytes: inflammation and immune cells in atherosclerosisMaxim E Annink, Jordan M Kraaijenhof, Erik S G Stroes, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|February 27, 2025
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemiaBram M Weijs, Reindert F Oostveen, Jordan M Kraaijenhof, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
European Heart Journal|November 28, 2025
The value of low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) in guiding cardiovascular preventionPaul M Ridker, Jordan M Kraaijenhof
JACC. Basic to Translational Science|June 16, 2023
Inflammatory Effects of Triglycerides: Relevant or Redundant?Jordan M Kraaijenhof, Erik S G Stroes
NEJM Evidence|February 6, 2024
Apolipoprotein C-III Inhibition - Killing Two Birds with One Stone?Jordan M Kraaijenhof, Erik S G Stroes
European Heart Journal|August 20, 2022
Different inflammatory pathways underlying cardiovascular risk in secondary preventionNick S Nurmohamed, Jordan M Kraaijenhof, Erik S G Stroes
European Heart Journal|July 24, 2025
A stitch in time: easily measured biomarkers to enhance cardiovascular risk prediction in primary preventionJordan M Kraaijenhof, Nick S Nurmohamed, Paul M Ridker
Current Atherosclerosis Reports|September 6, 2022
Lp(a): a New Pathway to Target?Nick S Nurmohamed, Jordan M Kraaijenhof, Erik S G Stroes
European Journal of Preventive Cardiology|May 9, 2026
ASCVD Risk Stratification Using Apolipoprotein B and the LDL-C to Total Cholesterol RatioBin Wang, Nick S Nurmohamed, Jordan M Kraaijenhof, et al.
Current Opinion in Lipidology|August 15, 2021
The iterative lipid impact on inflammation in atherosclerosisJordan M Kraaijenhof, G Kees Hovingh, Erik S G Stroes, et al.
Frontiers in Cell and Developmental Biology|August 20, 2024
Moving from lipids to leukocytes: inflammation and immune cells in atherosclerosisMaxim E Annink, Jordan M Kraaijenhof, Erik S G Stroes, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|February 27, 2025
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemiaBram M Weijs, Reindert F Oostveen, Jordan M Kraaijenhof, et al.
Pageof 4